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Background: Pathological levels of blood lipids could be one of the causes of sudden sensorineural hearing loss
(SSNHL). The objective of this manuscript is therefore to evaluate the relationship between blood lipid content and
sudden sensorineural hearing loss (SSNHL).
Methods: The correlation between serum lipid parameters, including total cholesterol (TC), triglycerides, high-density
lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein AI (apo AI),
apolipoprotein B (apo B), and lipoprotein A (Lp(a)), and the onset of SSNHL was analyzed from a data set of 250
patients and an age, gender and weight matched control group of 250 subjects.
Results: The result of single factor logistic regression shows that TC (p<0.01), LDL-C (p<0.01), and apo B (p=0.03) of
SSNHL group were significantly higher than those of the control group. The odds ratio of TC, LDL, and apo B are
higher than 1, while the confidence intervals of the odds rations do not include 1. No significant difference was
found with the prevalence of hypertension (P=0.818), diabetes (P=0.869) and smoking habits (P=0.653) between
SSNHL group and control group.
Conclusion: Total cholesterol, low density lipoprotein cholesterol and apolipoprotein B concentrations may be
important factors in the pathogenesis of sudden sensorineural hearing loss, and should be assessed during the
investigation of patients with this condition.
Keywords: Sudden Hearing Loss, Cholesterol, Low Density Lipoprotein Cholesterol, TriglyceridesBackground
Sudden sensorineural hearing loss (SSNHL) is generally
accepted by clinicians as a rapid hearing loss of >30 dB
in at least three contiguous frequencies over the course
of under 3 days [1]. Prevalence rates have been reported
as being from 5–20 per 100,000 people in the United
States, but this is likely to be an underestimate, since
many who recover quickly never seek medical attention
[2]. The prevalence in Asia has not been found signifi-
cantly different, with an estimate of 13 per 100,000
based on a survey of Japanese hospitals [3]. SSNHL is re-
portedly associated with many vascular and coagulation
diseases [2]. However, there is still debate as to the effect
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reproduction in any medium, provided the orInner ear function is greatly influenced by ischemia
since the blood supply of the inner ear is dependent
on the end arteriole [4]. Dyslipidemia is one of the
most significant cardiovascular risk factors [5], which
is also defined as a cardiovascular risk factor in the
Chinese population [6], and evidence has shown that
there is relationship between SSNHL and dyslipidemia
[7-9]. Lipid-lowering therapies have been correlated
with better hearing improvement in SSNHL patients
than a standard treatment control group [10]. However,
there are not enough large-scale clinical studies to sup-
port the correlation between SSNHL and dyslipidemia
[11-13], which limits the therapeutic development of
SSNHL. This study, a retrospective study into the
serum lipid data of 250 SSNHL patients, evaluates the
relationship between blood lipid and sudden sensori-
neural hearing loss.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 The average of serum lipid data of both groups







TC(mmol/L) 3.6-6.5 4.738±1.021 4.378±0.937
TG(mmol/L) 0-1.71 1.322±0.967 1.449±3.249
HDL-C(mmol/L) 1.1-1.7 1.432±0.401 1.459±0.420
LDL-C(mmol/L) 2.5-3.5 2.679±0.856 2.380±0.723
apoAI(g/L) 1.2-1.76 1.422±0.448 1.425±0.460
apoB(g/L) 0.6-1.14 0.695±0.266 0.645±0.242
Lp(a)(mg/L) 0-300 194.008±183.906 221.368±260.077
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Patients and controls
250 SSNHL patients (113 females and 137 males, with a
mean age of 56.41 years ranging from 15–84 years), ad-
mitted between January 1, 2007 and December 30, 2012
in a single clinical hospital in Nantong China, were in-
cluded in this study. The study was approved by and
performed in accordance with the ethical standards of
the hospital ethics committee. Patients included in the
study visited the hospital for the first time within 7 days
after the onset of SSNHL. Standard laboratory tests and
audiological diagnostic procedures were performed in
all subjects. We included patients with an average
hearing loss of more than 30 dB for speech frequen-
cies, and excluded patients if they had other diseases
that may cause hearing loss, such as otitis media, ototoxic
drugs, and noise trauma. We also excluded patients with
malignant disease psychiatric illness, dementia, hepatitis B
or C, or severe systemic diseases. A normal gender, age,
and weight matched group without hearing disease,
comprised of 250 patients scheduled for nasal endoscopic
surgery (e.g. functional endoscopic sinus surgery), was
used for comparison. The exclusion criteria were the same
as for the SSNHL group.
Test procedures
All hearing was evaluated by pure tone audiometry and
conducted in the same audiological laboratory using a
Madsen clinical audiometer (MADSEN midimate622
Diagnostic Audiometers). Inner ear CT scans or MRI
scans were performed in all the patients, and no inner ear
structural abnormality or tumors were found. The evalu-
ation was performed after hospital admission. Laboratory
parameters were also evaluated. Blood samples were
drawn from patients and control subjects after overnight
fast in the morning between 6 and 7 am. These parame-
ters included: total cholesterol (TC) concentration; low
density lipoprotein cholesterol (LDL-C); high density lipo-
protein cholesterol (HDL-C); triglycerides (TG); apolipo-
protein AI (Apo A1); apolipoprotein B (Apo B); and
lipoprotein A (Lp(a)). Any other standard tests indicated
by the physician were also performed. The following
ranges were considered normal: TC of 3.6-6.5 mmol/L;
LDL-C of 2.5-3.5 mmol/L; HDL-C:1.1-1.7 mmol/L; TG
of <2.0 mmol/L; apo AI: 1.2-1.76 g/L; apo B: 0.6-1.14 g/L;
and Lp(a): 0-300 mg/L.
Statistical analysis
Sigmaplot12 was used to perform statistical analyses. All
continuous variables were presented as mean±standard
deviation (x±SD). Single factor logistic regression was
carried out to analyze the correlation between serum
lipid parameters and the onset of SSNHL. It is assumed
the dependent variable of SSNHL group is “Y=1”, thedependent variable of control group is “Y=0”, and the
lipid parameters are independent variables. The chi-
square test was employed to compare the prevalence
of hypertension, diabetes and smoking habits between
SSNHL group and control group.
Results
The average of each parameter for both SSNHL and
control conditions can be seen in Table 1. The means of
serum lipid data of both groups were in the normal
range. Table 2 gives the result of single factor logistic re-
gression and Figure 1 shows that TC (p<0.01), LDL-C
(p<0.01), and apo B (p=0.03) of SSNHL group were sig-
nificantly higher than those of the control group. Figure 2
shows the odds ratio of TC, LDL, and apo B are higher
than “1”, while the confidence intervals of the odds ra-
tions do not include “1”. No significant difference was
found with the prevalence of hypertension (P=0.818),
diabetes (P=0.869) and smoking habits (P=0.653) be-
tween SSNHL group and control group.
Discussion
The etiology of SSNHL is not well understood at
present. There are different theories about its etiology
and risk factors of SSNHL are a topic of debate across
the literature [14]. Some clinical research indicates that
risk factors of SSNHL overlap those of cardiovascular
disease, such as hyperfibrinogenemia and smoking
[14,15]. As far as the correlation between dyslipidemia
and SSNHL, opinions vary. A clinical study of 86 sub-
jects in China showed that the levels of total choles-
terol (TC), triglyceride (TG), and lipoprotein A (Lp(a))
were significantly higher in patients with SSNHL than
in control subjects [15]. This study indicated plasma
viscosity, ratio viscosity of whole blood, reduced viscos-
ity of whole blood, high and low shear relative viscosity
of whole blood, index of red blood cells transmutation,
and fibrinogen level in the plasma of patients with
SSNHL were also significantly elevated in comparison
with those in control subjects. In a retrospective study,
Table 2 Single factor logistic regression shows TC, LDL-C, and apo B of SSNHL group are significantly higher than
those of control group, which indicate TC, LDL-C, and apo B correlate with SSNHL
Variants Regression coefficient b Standard error Wald statistic P value OR(95% CI)
TC 0.378 0.095 15.747 <0.01 1.459(1.211-1.758)
TG −0.0243 0.043 0.0317 0.574 0.976(0.897-1.062)
HDL-C −0.166 0.219 0.576 0.448 0.847(0.552-1.300)
LDL-C 0.488 0.120 16.451 <0.01 1.628(1.287-2.061)
apo AI −0.0167 0.198 0.007 0.933 0.983(0.667-1.450)
apo B 0.776 0.358 4.699 0.030 2.173(1.077-4.385)
Lp(a) −0.0005 0.0004 1.820 0.177 0.999(0.999-1.000)
The confidence intervals of odds ratio don’t include “1”.
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nificantly higher plasma concentrations of cholesterol
and low-density lipoprotein cholesterol, compared with
controls [7]. However, their test group was on average
15 years older than the control group, which may have
influenced the results. In addition, it is suggested that
fibrinogen/LDL apheresis may improve cochlear blood
flow by acutely decreasing plasma cholesterol and
fibrinogen [11,12]. However, it is hard to say whether
the therapeutic effect is gained from lowing fibrinogen
or LDL. There are also some negative reports of the
relationship between dyslipidemia and SSNHL [14]. In
order to add to the clinical evidence of this problem
and to avoid selection bias, we carried out this retro-
spective study with the data of SSNHL patients in a
medium-sized clinical hospital of Nantong, China,
which is a moderately developed medium-sized city,
instead of major medical institutions.Figure 1 Comparison of TC (total cholesterol) and LDL-C (low density
hearing loss) group and control group.It is generally accepted that serum lipid level is corre-
lated with age and body mass index (BMI) [16,17].
Therefore, we matched our disordered group with nor-
mal subjects who have the same age, gender and similar
weight to avoid these confounding factors. It is also be-
lieved hypertension, diabetes and smoking habits could
impair vascular tone and integrity in the vascular bed of
the ears, thus could promoting SSNHL [4]. We compared
the prevalence of hypertension, diabetes and smoking
habits between the SSNHL and control groups, and no
significant difference was found. The average of serum
lipid data of both groups is in the normal range. Similar
results have been reported in previous studies [7,9].
Approximately 40% of LDL particles are enriched with
cholesterol, so serum LDL-C levels are related to TC
level. A batch of clinical and epidemiological studies
demonstrate a continuous, graded relationship of serum
LDL level to long-term risk of coronary heart disease andlipoprotein cholesterol) between SSNHL (sudden sensorineural
Figure 2 Odds ratio and confidence interval of lipid parameters (TC- total cholesterol; TG- triglycerides; HDL-C- high density lipoprotein
cholesterol; LDL-C- low density lipoprotein cholesterol; Apo A1- apolipoprotein A1; Apo B- apolipoprotein B; Lp(a)- lipoprotein A).
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vascular wall through endothelial cells and is detained in
subendothelial tissue and converted to the oxidized form
(Ox-LDL). Macrophages are engulfed by Ox-LDLs and
converted into xanthoma cells. The proliferation and co-
alescing of xanthoma cell then turns into the lipid core of
an atherosclerotic plaque. Therefore, serum level of TC
and LDL-C are closely related with thrombotic diseases
and some scholars believe cardiovascular risk also has a
significant impact on the onset of SSNHL [20,21]. Mean-
while, high cholesterol not only affects the inner ear
blood supply [21], but can also affect the activities of
outer hair cells by damaging their structure [22]. Apo B
is an elementary composition of LDL-C, which is essen-
tial for the binding of LDL particles to the LDL receptor,
allowing cells to internalize LDL and thus absorb choles-
terol. A considerable amount of data exists to indicate
that apo B is a strong predictor of CVD risk [23]. Our
study has shown that TC, LDL-C, and apo B of SSNHL
group are significantly higher than those of the control
group, which correlates well with the mechanism of these
serum lipid parameters leading to CVD. On the other
hand, HDL-C and apo AI are considered to be protective
factors of CVD [24]. In this study, SSNHL patients also
showed lower HDL-C and apo AI level than controls but
this trend was not statistically significant.
As far as mechanism is concerned, there are a lot of
studies indicating that dyslipidemia can cause SSNHL by
affecting the inner ear blood supply. An animal experi-
ment shows endothelial dysfunction in cerebral arteri-
oles were significantly increased in apoE(−/−) mice onthe high-fat diet >6 months compared with the control
group [25]. Another animal experiment found that blood
flow in the cochleas was reduced significantly in hyper-
tensive rats exposed to an atherogenic diet compared to
that of normotensive or hypertensive control animals
[26]. It is generally accepted that Nitric oxide, a potent
vasodilator plays an extremely important role in the
blood supply of inner ear [27]. LDL cholesterol can impair
NO release, influencing the blood supply of inner ear,
while dyslipidemia [28]. On the other hand, dyslipidemia
can cause SSNHL by damaging the inner ear structure.
After the administration of a hyperlipid diet for 3 months,
histochemical study of the guinea pigs’ inner ear
revealed variations in lipid metabolism and partial
disorders of the outer hair cells while electron micro-
scopic observations showed vacuolar and parenchymal
protrusions on the surfaces of the striavascularis and
Corti’s organ [29]. It has also been reported that cho-
lesterol has different distributions among outer hair
cell membranes, and when water-soluble cholesterol is
incorporated into the cells, the outer hair cell lateral
wall stiffness parameter increases, which impairs the
activity of outer hair cell [22].
One of the major limitations of this study is the observa-
tional design. In order to avoid bias, we tried to collect
as much patient data as possible. Since dyslipidemia
may cause SSNHL by affecting the inner ear blood
supply with the forming of atherosclerosis plaque, which
is also the pathogeny of cardiovascular disease, we did
not exclude the patients with CVD. However, no other
vascular studies were done in all patients.
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This retrospective study of 250 SSNHL patients indicates
total cholesterol and low density lipoprotein cholesterol
concentrations may be important factors in the patho-
genesis of sudden sensorineural hearing loss, and should
be assessed during the investigation of patients with this
condition.
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